Thinking about cancer or dealing with cancer risk can be scary or overwhelming, but we believe that receiving information and resources is comforting, empowering, and lifesaving.
For people diagnosed with cancer, some treatment studies cover the cost for genetic testing as part of the study.
For people who have been diagnosed with cancer, some targeted therapy studies, such as PARP inhibitor studies, include genetic testing for people who qualify for participation. You can view the PARP inhibitor studies enrolling patients on our Featured Research Page or by searching our HBOC Research Search Tool and putting the word PARP in the search field.
Ashkenazi Jewish women and men aged 25 and older in the New York region can undergo testing for the BRCA founder mutations as part of a research initiative. The reduced cost is made possible by a collaboration between Program for Jewish Genetic Health (PJGH) and Montefiore Health System. This initiative makes the testing available to Ashkenazi Jewish adults, regardless of BRCA-related cancer history or their insurance/financial situation. Interested individuals should visit the PJGH BRCAcommunity Study website for more information.